Literature DB >> 2373815

Increased intracardiovascular clotting in patients with chronic atrial fibrillation.

K Kumagai1, M Fukunami, M Ohmori, A Kitabatake, T Kamada, N Hoki.   

Abstract

To clarify whether the formation of thrombi could be induced by atrial fibrillation itself or by factors predisposing to atrial fibrillation such as mitral stenosis, plasma D-dimer levels (cross-linked fibrin degradation products) were measured in 73 patients without atrial fibrillation (Group 2). In Group 1, 49 of the 73 patients had factors predisposing to atrial fibrillation such as valvular heart disease, and the remaining 24 had lone atrial fibrillation. In Group 2, 16 patients had organic heart disease and the remaining 5 had a chest pain syndrome. The plasma D-dimer level was significantly higher in Group 1 (150 +/- 19 ng/ml) than in Group 2 (61 +/- 3 ng/ml) (p less than 0.01, mean +/- standard error of the mean). In both groups, there were no significant differences in plasma D-dimer level between patients with and without organic heart disease (146 +/- 18 versus 156 +/- 46 ng/ml in Group 1; 61 +/- 4 versus 59 +/- 10 ng/ml in Group 2). These findings indicate that atrial fibrillation itself may be more important than factors predisposing to atrial fibrillation in the development of intracardiovascular clotting.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373815     DOI: 10.1016/0735-1097(90)90589-h

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation.

Authors:  Mónica Acevedo; Ramón Corbalán; Sandra Braun; Jaime Pereira; Ilse González; Carlos Navarrete
Journal:  J Thromb Thrombolysis       Date:  2012-02-03       Impact factor: 2.300

Review 2.  Atrial fibrillation in carcinoid heart disease: The role of serotonin. A review of the literature.

Authors:  C Langer; C Piper; J Vogt; J Heintze; T Butz; O Lindner; W Burchert; C Kersting; D Horstkotte
Journal:  Clin Res Cardiol       Date:  2006-11-24       Impact factor: 5.460

3.  Hypercoagulability and haemodynamic abnormalities in atrial fibrillation.

Authors:  G Y Lip
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

4.  Atrial fibrillation and stroke: what we know, what's new, and what we should do now.

Authors:  C S Landefeld
Journal:  CMAJ       Date:  1997-09-15       Impact factor: 8.262

5.  Pharmacologic strategies for the prevention of stroke in patients with atrial fibrillation.

Authors:  Greg Flaker; Richard Weachter
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

Review 6.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

7.  Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.

Authors:  R M Heppell; K E Berkin; J M McLenachan; J A Davies
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

Review 8.  Cardioversion of atrial fibrillation.

Authors:  G Y Lip
Journal:  Postgrad Med J       Date:  1995-08       Impact factor: 2.401

9.  Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?

Authors:  Eleni Hatzinikolaou-Kotsakou; Zarifis Kartasis; Dimitrios Tziakas; Athanasios Hotidis; Dimitrios Stakos; Konstantinos Tsatalas; Georgios Bourikas; Maria E Kotsakou; Dimitrios I Hatseras
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

10.  Diagnostic value of D-dimer and antithrombin-III levels in predicting prosthetic heart valve thrombosis.

Authors:  Cem Nazli; Ozan Kinay; Bahanttin Tunc; Oktay Ergene; Omer Gedikli; Ali Ayata; Abdullah Dogan; Ahmet Altinbas; Ulku Ergene; Mehmet Ozaydin; Turan Yavuz; Halil Kahraman
Journal:  Tex Heart Inst J       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.